Showing results (391-400 of 464) with videos related to
Sort By:
Pageof 47
Clinical Case Reports|April 3, 2025
Immunoglobulin G4-Related Disease of the Sternoclavicular Joint: A Case ReportRemi Mizuta, Shinnosuke Takemoto, Mutsumi Ozasa, et al.Oncology|September 13, 2022
A Randomized Phase 2 Study of 5-Aminolevulinic Acid Hydrochloride and Sodium Ferrous Citrate for the Prevention of Nephrotoxicity Induced by Cisplatin-Based Chemotherapy of Lung CancerKodai Kawamura, Hidekazu Matsushima, Hiroshi Sakai, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[Cetuximab improved the poor performance status of a colorectal cancer patient]Hideki Sakisaka, Takeshi Kato, Yoshinori Kagawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Pathological complete response in advanced gastric carcinoma with lymph node metastasis treated with combination neoadjuvant chemotherapy comprising S-1 and cisplatin-a case report]Tadayoshi Hashimoto, Atsushi Takeno, Hirokazu Taniguchi, et al.American Journal of Hematology|May 30, 2012
Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphomaKohei Tada, Sung-Won Kim, Yoshitaka Asakura, et al.The Oncologist|February 12, 2020
A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)Tetsuji Terazawa, Jin Matsuyama, Masahiro Goto, et al.Oncology|August 20, 2023
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-PaclitaxelFuyumi Nishihara-Kato, Hisao Imai, Takeshi Tsuda, et al.Molecular and Clinical Oncology|January 13, 2021
Relationship between cervical esophageal squamous cell carcinoma and human papilloma virus infection and gene mutationsMasaru Fukahori, Ken Kato, Hirokazu Taniguchi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 24, 2020
Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of ALK-Rearranged Lung CancerSachiko Arai, Shinji Takeuchi, Koji Fukuda, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2025
Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small Cell Lung Cancer Harboring EGFR MutationShintaro Kanda, Seiji Niho, Takayasu Kurata, et al.Pageof 47